Haemonetics Target Price

See Haemonetics's analyst price targets ($120) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$127.52

Average Target Price

$116.40

8.7% downside

10 analysts in the last 4 months

High: $140 | Low: $95

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-10-09	Mizuho SecuritiesAnthony Petrone	$140	9.8% upside
2026-10-09	Barrington	$140	9.8% upside
2026-10-08	BTIG	$130	1.9% upside
2026-09-03	Raymond JamesAndrew Cooper	$125	2% downside
2026-08-21	Robert W. Baird	$119	6.7% downside
2026-08-19	Barrington	$118	7.5% downside
2026-08-07	Raymond James	$105	17.7% downside
2026-08-07	Barrington	$95	25.5% downside
2026-08-07	Robert W. Baird	$96	24.7% downside
2026-08-06	BTIGMarie Thibault	$96	24.7% downside
2026-06-15	Mizuho SecuritiesAnthony Petrone	$85	33.3% downside
2026-05-12	Barrington	$89	30.2% downside
2026-05-08	Robert W. BairdDavid Rescott	$67	47.5% downside
2026-04-13	Mizuho SecuritiesAnthony Petrone	$70	45.1% downside
2026-02-06	Robert W. Baird	$81	36.5% downside
2026-02-06	Barrington	$94	26.3% downside
2026-02-06	Mizuho Securities	$80	37.3% downside
2026-01-12	Barrington	$93	27.1% downside
2025-12-17	Mizuho Securities	$90	29.4% downside
2025-12-15	Robert W. Baird	$99	22.4% downside
2025-11-14	Raymond JamesAndrew Cooper	$90	29.4% downside
2025-11-06	BTIG	$88	31% downside
2025-08-07	NeedhamMike Matson	$68	46.7% downside
2024-11-08	Raymond JamesAndrew Cooper	$120	5.9% downside
2024-09-13	C.L. KingKristen Stewart	$116	9% downside
2024-09-11	Bank of America SecuritiesCraig Bijou	$85	33.3% downside
2024-06-12	NeedhamMike Matson	$112	12.2% downside

Haemonetics (HAE) FAQ

Haemonetics (HAE) currently reports a target price of $120. Use the charts on this page to explore Haemonetics's target price history and peer comparisons.

Analysts' average 12-month price target for Haemonetics is $120, about 8.7% downside from the current share price of $127.52. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $120, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Haemonetics, and consider following HAE for alerts when major investors trade the stock.

Haemonetics is classified in the Healthcare sector. On target price, it currently shows $120. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HAE with unrelated industries.